Search Orphan Drug Designations and Approvals
-
Generic Name: | zanidatamab |
---|---|
Date Designated: | 12/18/2019 |
Orphan Designation: | Treatment of Biliary Tract Cancer |
Orphan Designation Status: | Designated |
FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
Sponsor: |
Jazz Pharmaceuticals Ireland Limited 3170 Porter Drive Palo Alto, California 94304 United States The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-